Molecular biophysics and inhibition mechanism of influenza virus A M2 viroporin by adamantane-based drugs - Challenges in designing antiviral agents. [PDF]
Georgiou K, Kolokouris D, Kolocouris A.
europepmc +1 more source
Abstract Background Fennel (Foeniculum vulgare Mill.) is a widely cultivated vegetable and aromatic‐medicinal plant. In this research, field studies assessed 12 fennel genotypes of diverse origin, comprising 10 Greek accessions and two European commercial varieties, focusing on their morpho‐agronomical traits, phenolic compounds and antioxidant ...
Kalliopi I. Kadoglidou +6 more
wiley +1 more source
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter? [PDF]
Smirne C +17 more
europepmc +1 more source
The effects of royal jelly on human health: A narrative review of clinical studies
Abstract Royal jelly (RJ) is a natural bioactive substance with documented effects on human health. This narrative review synthesizes evidence from clinical and clinically relevant experimental studies evaluating the therapeutic potential of RJ.
Goras Georgios +2 more
wiley +1 more source
Pseudovirus-Based Systems for Screening Natural Antiviral Agents: A Comprehensive Review. [PDF]
Trischitta P +3 more
europepmc +1 more source
A Comparison of Active Pharmacovigilance Strategies Used to Monitor Adverse Events to Antiviral Agents: A Systematic Review. [PDF]
Ferreira-da-Silva R +7 more
europepmc +1 more source
Direct-Acting Antiviral Agents in Prevention of Maternal-Fetal Transmission of Hepatitis C Virus in Pregnancy. [PDF]
Hartley C, Van T, Karnsakul W.
europepmc +1 more source
Exploring the potential of some natural indoles as antiviral agents: quantum chemical analysis, inverse molecular docking, and affinity calculations. [PDF]
Belal A +10 more
europepmc +1 more source
Investigation of the long-term effects of high-potency antiviral agents on aspartate aminotransferase-to-platelet ratio index and fibrosis index based on four factors: five-year outcomes in hepatitis B e-antigen-negative chronic hepatitis B patients. [PDF]
Arslan M, Cavnar AM, Çetin Ş.
europepmc +1 more source

